NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,066 | +0.9% | 89 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,981 | +306.7% | 89 | +270.8% | 0.00% | +200.0% |
| Q1 2023 | $2,208 | +1.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,177 | -99.9% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,824,000 | -10.1% | 24 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,029,000 | -9.8% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,250,000 | +7.2% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,099,000 | +6.9% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,963,000 | -4.3% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,052,000 | -9.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,266,000 | +8.6% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,087,000 | -0.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,096,000 | +104700.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | 0.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,000 | 0.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |